1. Home
  2. INVZ vs GNLX Comparison

INVZ vs GNLX Comparison

Compare INVZ & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVZ
  • GNLX
  • Stock Information
  • Founded
  • INVZ 2016
  • GNLX 2001
  • Country
  • INVZ Israel
  • GNLX United States
  • Employees
  • INVZ N/A
  • GNLX N/A
  • Industry
  • INVZ Auto Parts:O.E.M.
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVZ Consumer Discretionary
  • GNLX Health Care
  • Exchange
  • INVZ Nasdaq
  • GNLX Nasdaq
  • Market Cap
  • INVZ 114.2M
  • GNLX 103.6M
  • IPO Year
  • INVZ N/A
  • GNLX 2023
  • Fundamental
  • Price
  • INVZ $1.15
  • GNLX $2.27
  • Analyst Decision
  • INVZ Buy
  • GNLX Strong Buy
  • Analyst Count
  • INVZ 6
  • GNLX 4
  • Target Price
  • INVZ $3.81
  • GNLX $18.25
  • AVG Volume (30 Days)
  • INVZ 6.1M
  • GNLX 142.7K
  • Earning Date
  • INVZ 11-13-2024
  • GNLX 11-14-2024
  • Dividend Yield
  • INVZ N/A
  • GNLX N/A
  • EPS Growth
  • INVZ N/A
  • GNLX N/A
  • EPS
  • INVZ N/A
  • GNLX N/A
  • Revenue
  • INVZ $33,158,000.00
  • GNLX $8,000.00
  • Revenue This Year
  • INVZ $18.38
  • GNLX N/A
  • Revenue Next Year
  • INVZ $244.43
  • GNLX N/A
  • P/E Ratio
  • INVZ N/A
  • GNLX N/A
  • Revenue Growth
  • INVZ 339.99
  • GNLX N/A
  • 52 Week Low
  • INVZ $0.45
  • GNLX $1.60
  • 52 Week High
  • INVZ $2.82
  • GNLX $16.60
  • Technical
  • Relative Strength Index (RSI)
  • INVZ 69.41
  • GNLX 38.68
  • Support Level
  • INVZ $1.05
  • GNLX $2.13
  • Resistance Level
  • INVZ $1.37
  • GNLX $2.80
  • Average True Range (ATR)
  • INVZ 0.14
  • GNLX 0.20
  • MACD
  • INVZ 0.05
  • GNLX -0.04
  • Stochastic Oscillator
  • INVZ 70.98
  • GNLX 14.21

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Share on Social Networks: